Overall, for most tumor types tested in this study, our data revealed highly variable POSTN expression levels in both tumors and normal tissues, suggesting that larger numbers of samples should be tested to address periostin expression in tumors more significantly. This evidence concerns the gene POSTN and neoplasm.